Acute myeloid leukemia (AML) is a clonal disorder evolving from myeloid progenitor cells on the background of a number of genetic changes including balanced translocations[1][1] [2][2] and alterations of tumor suppressor genes and proto-oncogenes.[3][3]Recently, transcriptional silencing of tumor
No takes yet. Share an insight, caveat, or question.
Aggerholm et al. (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: